Genetic Test Helps ID Benign Versus Malignant Thyroid Nodules
ThyroSeq v3 has 94 percent sensitivity, 82 percent specificity for Bethesda III and IV nodules
Progress Toward Goals in Global Health Is Slowing
Seven articles published in the The Lancet address different aspects of the global burden of disease
Many Women Have Not Heard of Ovarian Cancer Before Dx
Nine in 10 women experience multiple symptoms prediagnosis; eight in 10 of them consult a doctor
FDA to Ban Most Flavored Electronic Cigarettes
Details of the ban expected to be announced next week
Improved Long-Term Pregnancy Outcomes for Goserelin + Chemo
Findings seen in premenopausal women with stage I to IIIA hormone receptor-negative breast cancer
More Frequent Surveillance No Benefit After NSCLC Resection
More frequent postsurgical surveillance is not associated with improved survival
Addition of Elotuzumab Ups PFS in Refractory Multiple Myeloma
In phase 2 trial, longer progression-free survival for elotuzumab with pomalidomide and dexamethasone
Medicaid Expansion Approved in Three Republican-Leaning States
Voters supported expansion in Utah, Nebraska, and Idaho
Low-Dose Radiation Safe for Low-Risk Thyroid Cancer
No increased risk for recurrence with 1.1 GBq versus 3.7 GBq RAI at 3-, 5-, 7-year follow-up
Blood Donations Exceeded Demand After Las Vegas Shooting
Almost 800 units of blood donated by public citizens after shooting; more than 17 percent wasted
